Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Postoperative analgesia after total hip arthroplasty: patient-controlled analgesia versus transdermal fentanyl patch
Ist Teil von
Journal of clinical anesthesia, 2008-06, Vol.20 (4), p.280-283
Ort / Verlag
New York, NY: Elsevier Inc
Erscheinungsjahr
2008
Quelle
MEDLINE
Beschreibungen/Notizen
Abstract Study Objective To determine whether a new transdermal fentanyl patch (TFP) is a good choice for the postoperative pain management of patients undergoing primary total hip arthroplasty compared with patient-controlled analgesia (PCA). Design Randomized, prospective study. Setting University hospital. Patients 30 patients undergoing primary total hip arthoplasty. Interventions Patients received either a TFP (group T; Duragesic 50 μ g/h, matrix fentanyl patch, Janssen-Cilag) applied approximately 10 hours before induction of general anesthesia and PCA programmed in the postanesthesia care unit (PACU), or PCA programmed in the PACU (group P). Measurements Intraoperative sufentanil and additional postoperative morphine administration were recorded, as well as visual analog scores and routine vital signs at predetermined intervals during the first 48 hours. Main Results Morphine consumption on arrival in the PACU was 3.5 ± 3 mg in group T versus 13 ± 5 mg in group P ( P < 0.0001). Visual analog scores on arrival in the PACU were 37 ± 22 mm in group T versus 73 ± 13 mm in group P ( P < 0.0001). Cumulative morphine consumption at the 24th hour was 43 ± 16 mg in group P and 4 ± 3 mg in group T ( P < 0.0001). Cumulative morphine consumption at the 48th hour was 54 ± 26 mg in group P and 5 ± 4 mg in group T ( P < 0.0001). Intraoperative sufentanil consumption was 38 ± 15 μ g in group T versus 30 ± 5 μ g in group P (not significant). The sedation score was 0 in both groups during the first 48 postoperative hours. Conclusions Preoperative TFP application decreases pain scores and morphine consumption in the PACU and appears to have prolonged effects spanning the first 48 postoperative hours.